Michael C. Gutkin

Michael C. Gutkin

Auto-generated profile, based on publicly available information

Michael C. Gutkin

Center for Discovery and Innovation, Hackensack University Medical Center, Nutley, NJ 07110, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2025 in Science Immunology
Verified
Journal Article
Closed access
PRPradeep Ramalingam
Pradeep Ramalingam
MGMichael C. Gutkin
Michael C. Gutkin
MPMichael G. Poulos
Michael G. Poulos
AWAgatha Winiarski
Agatha Winiarski
ASArianna Smith
Arianna Smith
JBJason M. Butler
Jason M. Butler
Chronic low-grade inflammation observed in older adults, termed inflammaging, is a common feature underlying a multitude of aging-associated maladies including a decline in hematopoietic activity. However, whether suppression of inflammaging can preserve hematopoietic health span remains unclear, in part because of a lack of tools to measure inflammaging within hematopoietic stem cells (HSCs). Here, we identify thrombospondin-1 (Thbs1) as an essential regulator of inflammaging within HSCs. We describe a transcriptomics-based approach for measuring inflammaging within stem cells and demonstrate that deletion of Thbs1 is sufficient to prevent HSC inflammaging. Our results demonstrate that suppression of HSC inflammaging prevents aging-associated defects in hematopoietic activity including loss of HSC self-renewal, myeloid-biased HSC differentiation, and anemia. Our findings indicate that suppression of HSC inflammaging may also prolong overall systemic health span.